GeneDx Holdings Corp.
Canonical company identity and public leadership record.
- Source reported. 29 claims from 2 sources.
- Not claimed by the company.
- Eval: not assessed.
- Chair
- Keith Meister
- Board
- 5 directorsAlpha calculation. Published seats
- Committees
- 3
- Evidence
- 2 sources29 published claims
- Open conflicts
- 0None open
Leadership
3 claims| Person | Role | Since | Status | Evidence |
|---|---|---|---|---|
| Bryan Dechairo | Chief Operating Officer | Not captured | Unknown | Source reportedE2 |
| Katherine Stueland | Chief Executive Officer | Not captured | Unknown | Source reportedE2 |
| Kevin Feeley | Chief Financial Officer | Not captured | Unknown | Source reportedE2 |
Board
9 claims| Director | Status | Since | Committees | Evidence |
|---|---|---|---|---|
| Eli Casdin | Independence not published | Compensation Committee; Nominating and Corporate Governance Committee | Source reportedE3 | |
| Emily Leproust | Independence not published | AUDIT COMMITTEE; Compensation Committee; Nominating and Corporate Governance Committee, chair | Source reportedE3 | |
| Joshua Ruch | Independence not published | Compensation Committee, chair; Nominating and Corporate Governance Committee | Source reportedE3 | |
| Richard C. Pfenniger, Jr | Independence not published | AUDIT COMMITTEE | Source reportedE3 | |
| Thomas Fuchs | Independence not published | None published | Source reportedE3 | |
| Emily Leproust, Ph.D. | Independent | Not published | None published | Source reportedE2 |
| Katherine Stueland | Not independent | Not published | None published | Source reportedE2 |
| Keith Meister | Independent; Chair | Not published | AUDIT COMMITTEE, chair | Source reportedE2 |
| Thomas Fuchs, Ph.D. | Independent | Not published | None published | Source reportedE2 |
Committees
12 claims| Committee | Chair | Members | Risks assigned | Evidence |
|---|---|---|---|---|
| AUDIT COMMITTEE | Keith Meister | Keith Meister, Emily Leproust, Richard C. Pfenniger, Jr | Not described in the published record | Source reportedE4 |
| Compensation Committee | Joshua Ruch | Joshua Ruch, Eli Casdin, Emily Leproust | Not described in the published record | Source reportedE4 |
| Nominating and Corporate Governance Committee | Emily Leproust | Emily Leproust, Eli Casdin, Joshua Ruch | Not described in the published record | Source reportedE4 |
| Fact | Stated value | Evidence |
|---|---|---|
| Committee appointment | Keith Meister: chair, AUDIT COMMITTEE | Source reportedE4 |
| Committee appointment | Emily Leproust: member, AUDIT COMMITTEE | Source reportedE4 |
| Committee appointment | Richard C. Pfenniger, Jr: member, AUDIT COMMITTEE | Source reportedE4 |
| Committee appointment | Joshua Ruch: chair, Compensation Committee | Source reportedE4 |
| Committee appointment | Eli Casdin: member, Compensation Committee | Source reportedE4 |
| Committee appointment | Emily Leproust: member, Compensation Committee | Source reportedE4 |
| Committee appointment | Emily Leproust: chair, Nominating and Corporate Governance Committee | Source reportedE4 |
| Committee appointment | Eli Casdin: member, Nominating and Corporate Governance Committee | Source reportedE4 |
| Committee appointment | Joshua Ruch: member, Nominating and Corporate Governance Committee | Source reportedE4 |
Financial context
2 claims| Fact | Stated value | Evidence |
|---|---|---|
| Security listing | WGS (NASDAQ) | Source reportedE1 |
| Security listing | WGSWW (NASDAQ) | Source reportedE1 |
Other published claims
3 claims| Fact | Stated value | Evidence |
|---|---|---|
| Legal name | GeneDx Holdings Corp. | Source reportedE1 |
| Entity status | Public listing published | Source reportedE1 |
| Published fact | US | Source reportedE1 |
Evidence
4 evidence records| Ref | Source | Authority | Source date | Retrieved | Rights | Cited by |
|---|---|---|---|---|---|---|
| E1 | Alpha canonical company public projectionCanonical identity | Open web | Not recorded | Rights not recorded, link only | 5 claims | |
| E2 | SEC DEF 14A 0001818331-26-000030SEC def 14a | Authoritative, regulatory filing | Rights not recorded, link only | 7 claims | ||
| E3 | DEF 14A wgs-20260430.htmSEC proxy | Authoritative, regulatory filing | Rights not recorded, link only | 5 claims | ||
| E4 | AUDIT COMMITTEEgovernance_people_committees. SEC proxy | Authoritative, regulatory filing | Not recorded | Not recorded | Rights not recorded, link only | 12 claims |
No evidence record is pinned or signed yet.
Not yet in this record
These parts of a company record have no published claims yet. That is a coverage state, not a finding about the company. 1 further claim is under review.
- Control and voting
- Governance
- Risk
- AI oversight
- Legal
- Compensation
Index memberships
No current membership is published in Alpha's tracked index universe.
This is not evidence that the company is absent from every market index.
As of 22 Nov 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
Coverage states the record reports (12)
- Corporate structure
- Not reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- Ownership
- Not reviewed. Ownership and voting power determine who can influence the board.
- Financials
- Not reviewed. Governance-relevant financial context frames capital and audit decisions.
- Compensation
- Not reviewed. Pay design shows how incentives are governed.
- Governance
- Not reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governance
- Not reviewed. Meeting and vote records show shareholder dissent and support.
- Audit
- Not reviewed. Auditor, controls and restatements show assurance over reporting.
- Legal
- Not reviewed. Material legal and regulatory matters show enforcement exposure.
- Risk
- Not reviewed. Risk ownership links the board, committees, executives and controls.
- Cyber
- Not reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governance
- Not reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets external
- Not reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
Limits of this record (5)
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
History
Version public-1Published .
- Director appointed. Thomas Fuchs seat on GeneDx Holdings Corp., effective 2025.Effective . Recorded .
- Director appointed. Richard C. Pfenniger, Jr seat on GeneDx Holdings Corp., effective 2022.Effective . Recorded .
- Director appointed. Joshua Ruch seat on GeneDx Holdings Corp., effective 2021.Effective . Recorded .
- Director appointed. Eli Casdin seat on GeneDx Holdings Corp., effective 2020.Effective . Recorded .
- Director appointed. Emily Leproust seat on GeneDx Holdings Corp., effective 2020.Effective . Recorded .
About this record
- Alpha ID
- alpha:company:365a85a4-d81e-481c-bc67-fee6be34f442
- Version
- public-1:ro-d751713988987e9331980363e24189ce
- Identity
- Not claimed
- Evidence
- Source reported
- Evaluation
- Not assessed
- Monitoring
- Not monitored yet
- Authority
- Not published
- Freshness
- Current
- Integrity
- Not signed yet
- Basis
- Published company record built from public sources
- Never published
- Private company data: deployments, authority grants, TrustChecks, receipts, telemetry
The company can claim this record and correct or dispute any claim. Corrections are versioned and the original stays in history. A company's own statements are shown as its own and never replace the cited evidence.

